Paladin in strategic relationship with Dutch specialty pharma
March 4, 2010 by stephenkilmer · Leave a Comment
Stepping beyond its Canadian market, Paladin Labs (TSX:PLB) is investing four million Euros through a secured convertible debenture in SpePharm Holding BV, a Dutch specialty pharma company, in a new relationship that “establishes significant future strategic collaboration and value potential for both parties.” Under the accord, Paladin can convert the debenture into an approximate 10% [...]
Listen to BioTuesdays 
